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ABSTRACT
Introduction: 25-hydroxyvitamin D (25OHD) is the principal biomarker of vitamin D status. In circulation, 25OHD 
is primarily bound to vitamin D binding protein (VDBP), leaving a small proportion bound to albumin and as free 
form. Previous studies have suggested that free 25OHD is better correlated with health outcomes. However, in 
pregnancy where VDBP level is extremely elevated, the correlations between free 25OHD with health outcomes are 
far from conclusive. Here we show the associations of maternal and cord total, free and bioavailable 25OHD con-
currently with neonatal anthropometric measurements in healthy pregnant mothers-neonates pairs. Method: Total 
25OHD level was measured by using chemiluminescent immunoassay. Free and bioavailable 25OHD were calcu-
lated using published mathematical models. Results: The results showed that birth weight and head circumference 
were negatively associated with maternal total 25OHD but not significantly associated with free and bioavailable 
25OHD. There were no significant associations between cord total, free and bioavailable 25OHD with any of the 
neonatal anthropometric measurements. Conclusion:  The outcomes of this study should encourage further research 
in a larger sample size. Notably, future research could lead to the establishment of causative relationships and plau-
sible mechanisms between maternal and cord 25OHD with neonatal anthropometric measurements.
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INTRODUCTION
25-hydroxyvitamin D (25OHD) is the prohormone 
of vitamin D. It is synthesised in the liver and then 
hydrolysed in the kidney to the active form of vitamin 
D-1,25-dihydroxyvitamin D (1,25OHD). Being the 
major circulating vitamin D metabolite and having a 
relatively long half-life, serum or plasma 25OHD has 
been used as the principal marker for vitamin D status 
(1, 2). In the circulation, about 80-90% of 25OHD is 
bound to vitamin D binding protein (VDBP) and about 
12% is bound to albumin, leaving less than one percent 
present as free form (3). The affinity of 25OHD for 
albumin is substantially weaker than that observed for 
VDBP. Hence, the albumin bound 25OHD plus free 
25OHD is referred to as bioavailable 25OHD (4). 
As the affinity of VDBP to 25OHD is high, VDBP bound 
25OHD is not available for passive diffusion into cells. 
The uptake of VDBP bound 25OHD is dependent on 
a transmembrane protein, megalin. In contrast, the 
relatively low affinity of albumin to 25OHD makes 
free and bioavailable 25OHD more diffusible. Thus, 
free and bioavailable 25OHD can passively diffuse 
into cells independent on megalin (4). Several studies 
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have revealed that free and bioavailable 25OHD were 
better correlated to the bone health markers and non-
calciotropic health outcomes than total 25OHD.  On the 
contrary, there are studies showing that the associations 
between outcomes with free 25OHD and bioavailable 
25OHD were not stronger than the associations with 
total 25OHD (5). 
The concentration of VDBP is two to three folds higher 
in pregnancy than in the non-pregnant state (6-8). 
The increase could be attributed to the stimulation of 
VDBP production by estrogen (9), but the functional 
significance of the elevation in VDBP so far remains 
unclear. Previous studies have consistently reported 
that the increase in maternal VDBP is concurrent with 
an increase in maternal total 1,25OHD. As a result, 
free 1,25OHD level in the circulation is maintained (6, 
7). However, the increase in 1,25OHD is expected to 
increase 25OHD expenditure, thus decreasing maternal 
total 25OHD. The increase of VDBP may lead to a 
decrease  in free and bioavailable 25OHD (10, 11). This 
can conserve bound 25OHD (8) for placental metabolism 
and transfer to fetus. In a review by Bikle et al.(5), it has 
been demonstrated that total 25OHD level is likely to 
be influenced by VDBP. They suggested that measuring 
free 25OHD may better reflect vitamin D sufficiency 
in pregnancy. Neonatal size at birth has been shown 
to affect perinatal morbidity and is associated with the 
risk of metabolic syndrome and disease development 
later in life (12, 13). In recent years, a growing body 
of literature has investigated the associations of vitamin 
D with neonatal size at birth. Some studies have found 
significant associations between maternal 25OHD with 
neonatal anthropometric measurements (14-16), while 
others did not (17, 18). Likewise, review and meta-
analyses on the associations between maternal and cords 
25OHD with neonatal size at birth have highlighted the 
inconsistency of the associations results (19, 20). This 
inconsistency can be explained by the heterogeneity 
of the study design between these studies: gestational 
age at sampling, study population, geographical region 
and controlled variables. Nevertheless, it is important 
to mention that most of these studies  investigated the 
associations of 25OHD  in maternal blood or cord 
blood with neonatal outcomes. While maternal 25OHD 
and cord 25OHD can confound each other for the 
associations with neonatal outcomes, limited studies 
assessed the associations concurrently in both maternal 
and cord blood. 
The inconsistency of vitamin D associations with 
neonatal anthropometric measurements could be due 
to free or bioavailable 25OHD rather than the total 
25OHD is associated with neonatal anthropometric 
measurements. Exploring the correlation between free 
and bioavailable 25OHD may partly unravel and explain 
the previous inconsistency in the associations of vitamin 
D  with neonatal anthropometric measurements at birth. 
However, to date, there has been limited evaluation on 
the concentration of free and bioavailable 25OHD with 
neonatal anthropometric measures at birth. Hence, this 
study is aimed to determine the relationship between 
maternal and cord total, free and bioavailable 25OHD. 
Furthermore, we examined the associations between 
maternal and cord total, free and bioavailable 25OHD 
with fetal last ultrasound biometry and neonatal 
anthropometric measurements. 
MATERIALS AND METHODS
Participants
Pregnant women delivering at Pantai Hospital, Kuala 
Lumpur, Malaysia during the study period were invited 
to participate in this study. Subjects were included if the 
following criteria were met: i) Malaysian, ii) aged 19 to 
40 years, iii) singleton pregnancy, iv) gestational age ≥ 37 
weeks. Pregnant women who were diagnosed with pre-
existing systemic disease or pregnancy complications or 
had a history of bone and renal disorders, as well as 
infants born with congenital anomalies, were excluded 
from this study. The study was approved by the Ethics 
Committee for Research Involving Human Subjects 
(JKEUPM) and was conducted in accordance with the 
Helsinki Declaration. Written consent was obtained 
from all participants before they took part in the study.
Power analysis was performed using G*Power software. 
Prior to this study, information on the coefficient 
of determinants between 25OHD and neonatal 
outcomes was unavailable. In general, the coefficient 
of determinants of 0.3 is considered sizeable (21). 
Thus, using a conservative estimate of coefficient of 
determinants of 0.3 with a 95% confidence interval, we 
calculated that present sample size of 77 had a power of 
77% to detect significance in the associations.
Measurement
Information on maternal age, pre-pregnancy weight, 
height, household income, education level, ethnicity and 
obstetric history were obtained through self-administered 
questionnaire. Information on first booking (date, weeks 
and ultrasound scan) and last booking (dates, weeks and 
biparietal diameter) were obtained from  the medical 
record book of each study participant. Gestational age 
was determined by last menstrual period (LMP) and 
confirmed by the first dating scan. The anthropometric 
measurements of newborn which include birth weight, 
head circumference, length and sex were obtained from 
hospital birth records. Ponderal index, an indicator of 
infant fatness was calculated using equation 1 (22). 
Ponderal index=     birth weight (kg)                   (1)
                          crown-to-heel length (m3)                   
Blood Collection and Laboratory Analysis 
Five milliliters of venous blood from the pregnant 
mother was collected prior to delivery and 5 mL of cord 
blood from the severed umbilical cord was collected 
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after delivery of the newborn, but before expulsion 
of placenta. These blood samples were centrifuged 
at 3700 rpm for 15 minutes at 4 °C, and the plasma 
aliquots were kept at -80 °C until analysis. Plasma 
total 25OHD was measured using chemiluminescent 
immunoassay (CLIA) via LIAISON analyser (DiaSorin 
Inc, Stillwater, MN, USA), an automated platform. 
The assay involved dissociation of 25OHD from its 
binding protein and binding of 25OHD to specific 
antibody on the solid phase, followed by the addition 
of tracer (vitamin D linked to an isoluminol derivative). 
Lastly, the starter reagents were added to initiate a 
flash chemiluminescent reaction. The light signal was 
measured by a photomultiplier as relative light units. The 
mean coefficient of variance (CV) for the assay was 5-6% 
and the limit of quantification (LoQ) was 12.5nmol/L. 
Maternal and neonatal plasma 25OHD levels were 
categorised according to previously described categories 
of vitamin D status (23-25): as vitamin D deficiency 
(<25 nmol/L), vitamin D insufficiency (25-50 nmol/L)
and vitamin D sufficiency (>50 nmol/L). The circulating 
Vitamin D binding protein (VDBP) was measured 
by using the Quantikine Human Vitamin D Binding 
Protein Immunoassay Kit (R&D Systems, Minneapolis, 
USA) according to the manufacturer’s instructions. The 
mean CV for the VDBP assay was 6%. Albumin was 
measured using immunoturbidimetric assay (Roche 
cobas c311, Mannheim, Germany). The concentration 
of free 25OHD  was calculated by using the equation 
from Powe et al. (26) (equation 2).  The affinity binding 
constants for 25OHD with albumin and VDBP used 
were 6 X 105 M-1 and 7 X 108 M-1, respectively. 
Bioavailable 25OHD was calculated as sum of free 
25OHD and albumin-bound 25OHD using equation 3 
(27).
Free 25OHD=                Total 25OHD                            (2)
                      1+(6 x105 x Albumin) + (7 x 108 x VDBP)          
Bioavailable 25(OH)D 
       = Free 25(OH)D + Albumin bound 25(OH)D            (3) 
Statistical Analysis 
All the statistical analyses were performed using IBM 
SPSS version 21.0. The characteristics of the study 
participants were described by number and percentage 
for categorical variables. Continuous variables were 
tested for normality using Smirnov-Kolmogorov test 
and skewness (≤+2 or ≤-2) and were described as mean 
and standard deviation or median and interquartile 
range. The associations between maternal and neonatal 
vitamin D metabolites (total, free, bioavailable 25OHD, 
vitamin D binding protein) were examined via Pearson 
correlation or Spearman correlation coefficient. 
Separate Generalized linear models (GLMz) were used 
to examine the associations between maternal and 
cord vitamin D metabolites with the last ultrasound 
biometry and anthropometric measures at birth. Then, 
the associations were controlled for potential covariates 
based on previous literature (pre-pregnancy BMI, 
gestational age at delivery or gestational age of last 
ultrasound scan and fetal sex) (15, 22, 28). GLMz was 
chosen because of its robustness as estimator in the 
absence of normality. Identity link function and gamma 
with log link were used. Deviance value, value/df and 
Akaike’s Information Criterion (AIC) were used in model 
selection. Statistical significance was set at p<0.05.
RESULTS
A total of 77 healthy mothers-neonates pairs were 
recruited. Majority (74.0%) of the respondents were 
highly educated Chinese, 68.4% and 21.1% of them 
were employed and self-employed, respectively (Table 
I). Despite all pregnant women consuming vitamin 
D-containing supplements, more than half (61.0%) 
of them were found to be vitamin D insufficient (<50 
nmol/L). Mean maternal total 25OHD was significantly 
lower than cord total 25OHD (mean 47.1 ± 14.7 nmol/L 
vs 57.0 ± 17.1 nmol/L, p<0.0001). Thus, 35.1% of 
neonates were found to be vitamin D insufficient. 
In both maternal and cord samples, total 25OHD 
was positively correlated with VDBP (r=0.239 and 
r=0.276 respectively) but not correlated with free and 
bioavailable 25OHD. Maternal total 25OHD was 
strongly correlated with cord total 25OHD (r=0.731, 
p<0.0001) and modestly correlated with cord VDBP 
(r=0.371, p<0.01). Maternal VDBP was positively 
correlated with cord VDBP but negatively correlated 
with cord free 25OHD and cord bioavailable 25OHD 
(r=0.455, -0.366 and -0.393, respectively). Maternal 
free 25OHD and maternal bioavailable 25OHD were 
both modestly correlated with cord free 25OHD and 
cord bioavailable 25OHD (Table II). 
Maternal total 25OHD was negatively associated with 
birth weight after adjusting for covariate (Table III). 
However, mothers with a lower total 25OHD was 
associated with larger head circumference in newborn 
(B=-0.042, P=0.011) after the adjustment. Similarly, 
maternal 25OHD was found negatively associated 
with biparietal diameter (BPD) in the crude model (B=-
0.001, P=0.006). However, this association did not 
reach significance (B=-0.001, P=0.065) after adjusting 
for cord total 25OHD, pre-pregnancy BMI, fetal sex 
and gestational age. Maternal total, free 25OHD and 
bioavailable 25OHD were not associated with length 
and Ponderal index in both crude and adjusted models. 
Cord total 25OHD was associated with BPD in the 
crude model. However, the association attenuated after 
adjusting with covariates and maternal total 25OHD 
(Table IV). There were no associations between cord 
total, bioavailable and free 25OHD concentration with 
any anthropometric measurements at birth.
DISCUSSION
We described a suboptimal vitamin D status among 
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Table I: Maternal and neonatal characteristics (n=77)
mean ± SD or medi-
an(Q1-Q3) or 
n (%) 
Maternal Characteristic 
Ethnicity
Chinese 57 (74.0)
Indian 18 (23.4)
Malay 2 (2.6)
Household Income: High (>RM5000) 44 (63.8)
Education level: Degree or higher, 70 (90.9)
Age (years) 33.4 ± 3.7
Pre-pregnancy weight (kg) 54.9 ± 8.1
Height (m) 160.5 ± 6.5
Pre-pregnancy body mass Index (kg/m2) 21.1 ± 2.6
Nulliparous 28 (38.4)
Vitamin D supplement intake
<10ug/day 33(42.9)
≥ 10ug/day 44(57.1)
Total 25OHD (nmol/L) 47.1 ± 14.7
Vitamin D status: Insufficiency (<50nmol/L) 47 (61.0)
Vitamin D binding protein (umol/L) 8.4 (3.7-18.4)
Bioavailable 25OHD (nmol/L) 0.8 (0.4-1.8)
Free 25OHD (pg/ml) 2.7 (1.5-5.7)
Neonates characteristics
Infant sex: 
Female 38(49.4)
Male 39 (50.6)
Last ultrasound Biparietal diameter (mm) 93.5(91.5-95.2)
Gestational age at last ultrasound (week) 38.0± 1.1
Gestational age at birth (week) 38.8 ± 0.9
Birth weight (kg) 3.2 ± 0.4
Head circumference at birth (cm) 34.2 ± 1.5
Crown-heel length (cm) 49.5 ± 2.6
Ponderal Index 25.6 (24.2-27.5)
Total 25OHD (nmol/L) 57.0 ± 17.1
Vitamin D status (<50nmol/L) 27 (35.1)
Vitamin D binding protein (umol/L) 3.6 (2.3-7.0)
Bioavailable 25OHD (nmol/L) 2.5 (1.3-3.5)
Free 25OHD (pg/ml) 7.3 (4.2-11.5)
Table II: Correlations with maternal and cord Total 25OHD, VDBP, Free 25OHD and Bioavailable
M Total 
25OHD
M VDBP M Free 25OHD M Bio 25OHD C Total 25OHD C VDBP C Free 25OHD C Bio 25OHD
M Total 25OHD 1 0.239c 0.067 0.115 0.731a 0.371b -0.013 -0.29
M VDBP 1 -0.889a -0.840a 0.228 0.455a -0.366b -0.393b
M Free 25OHD 1 0.971a -0.031 -0.427a 0.422a 0.460a
M Bio 25OHD 1 -0.023 -0.401b 0.435a 0.450a
C Total 25OHD 1 0.276c 0.179 0.159
C VDBP 1 -0.869a -0.872a
C Free 25OHD 1 0.992a
C Bio 25OHD 1
M, maternal; C, cord; Bio, Bioavailable; VDBP, Vitamin D binding protein 
ap<0.0001 bp<0.01 cp<0.05
Table III: Associations of maternal total 25OHD, free 25OHD and 
bioavailable 25(OHD) with infant anthropometric measurements
Birth weight (g)a HC (cm)a BPD (mm)b
B (SE) p B (SE) p B (SE) p
Maternal Total 25OHD
Crude -5.5 
(3.3)
0.091 -0.02 
(0.01)
0.074 -0.001 
(0.0004)
0.006
Adjustedc -10.1 
(4.4)
0.023 -0.04 
(0.02)
0.011 -0.001 
(0.0006)
0.065
Maternal Free 25OHD
Crude 2.7 (9.9) 0.786 0.003 
(0.04)
0.923 0.001 
(0.0013)
0.561
Adjustedd 5.9 (9.9) 0.554 0.007 
(0.04)
0.855 0.001 
(0.001)
0.553
Maternal Bio 25OHD
Crude 7.6 
(30.3)
0.804 0.004 
(0.11)
0.974 0.002 
(0.004)
0.580
Adjustede 15.6 
(30.3)
0.608 0.004 
(0.11)
0.894 0.002 
(0.004)
0.648
HC, Head circumference; BPD, Biparietal diameter; Bio, Bioavailable 
aValues from generalized linear model with normal distribution and identity link function
bValues from generalized linear model with gamma distribution and log link function.
cAdjusted for cord total 25OHD, maternal pre-pregnancy Body Mass Index, infant sex and 
gestational age.  
dAdjusted for cord free 25OHD, maternal pre-pregnancy Body Mass Index, infant sex and 
gestational age.  
eAdjusted for cord bioavailable 25OHD, maternal pre-pregnancy Body Mass Index, infant sex 
and gestational age.
pregnant women of high social economic status in Kuala 
Lumpur, Malaysia. Our estimate of 61% of maternal 
plasma with total 25OHD <50 nmol/L was higher 
than that reported among Chinese pregnant women in 
Singapore, where at the similar latitude as our study 
(Kuala Lumpur: 3.1390 N°; Singapore: 1.3521N°) (29). 
The high prevalence of maternal vitamin D insufficiency 
reported in this study was comparable with studies 
conducted among pregnant women at Poland (30), 
India (17) and United Kingdom (31). In this study, we 
did not intend to assess the determinants of vitamin D 
status. However, high vitamin D insufficiency reported 
in our study suggests that factors other than latitude, for 
example hours spent under the sun and dietary vitamin 
D intake, can be important determinants of vitamin D 
status in our study populations.  
The strong association between cord and maternal total 
25OHD at delivery reported in our study was consistent 
with findings from the previous studies (30, 32). Most 
of the studies reported lower total 25OHD level in cord 
Mal J Med Health Sci 16(1): 24-31, Jan 2020 28
through the placenta. 
In our studies, we observed the confounding effects 
of cord total 25OHD on the associations of maternal 
total 25OHD with several neonatal anthropometric 
measurements. For instances, maternal total 25OHD 
was not associated with all the neonatal anthropometric 
measurements except biparietal diameter in the crude 
mode. However, the associations between maternal 
total 25OHD with birth weight and head circumferences 
were significant after adjusting for cord total 25OHD 
and other variables. The finding that maternal total 
25OHD but not cord total 25OHD was associated 
with birth weight is in good agreement with Chun et 
al. (33). However, this finding was inconsistent with 
the finding by Lykkedegn et al. (16), which they found 
cord total 25OHD but not maternal total 25OHD was 
associated with birth weight. However, two studies 
showed both maternal and cord total 25OHD were not 
associated with birth weight (30, 38). The biological 
basis to explain the associations between vitamin D and 
neonatal anthropometric measurements at birth remains 
unclear. The significant association between maternal 
but not cord total 25OHD with birth weight suggests that 
the association is likely to be mediated by the placenta. 
Maternal 25OHD may affect fetal growth by regulating 
placental expression of specific genes that are involved 
in fetal growth. In agreement with this, a previous study 
has shown that vitamin D plays an important role in 
regulating placental amino acid transporters (39). 
The negative association between maternal 25OHD and 
birth weight may be attributed by the interaction effect 
of 25OHD with variables such as pre-pregnancy BMI 
and infant’s sex. Sauder et al. (15) reported a significant 
interaction between 25OHD with pre-pregnancy BMI 
for total mass. They found that among women with 
lower pre-pregnancy BMI, an increase in 25OHD was 
associated with a decrease in birth weight, whilst among 
women with higher pre-pregnancy BMI, an increase in 
25OHD was associated with an increase in birth weight. 
Our study population has low pre-pregnancy BMI (mean 
± SD: 21.1 ± 2.6 kg/m2). It is therefore not surprising that 
we observed negative associations between maternal 
total 25OHD with birth weight. In a study by Eggemoen 
et al. (28), there was sex differences in the associations 
of maternal total 25OHD with birth outcomes. Their 
study showed maternal total 25OHD was negatively 
associated with the sum of skinfolds in males but not in 
females. Nonetheless, our study had limited power to 
analyse the potential interactions between 25OHD with 
these variables.
Several studies have suggested that free 25OHD was 
better correlated with the markers of vitamin D and 
the endocrine system as well as bone health than total 
25OHD in both the pregnant (40) or non-pregnant 
state (5). However, the evidence is still inconsistent (5). 
Recently, a longitudinal study by Gustafsson et al. (11) 
Table IV: Associations of cord total 25OHD, free 25OHD and bio-
available 25(OHD) with infant anthropometric measurements
Birth weight (g)a HC (cm)a BPD (mm)b
B (SE) p B (SE) p B (SE) p
Cord Total 25OHD
Crude -1.3 (2.9) 0.652 -0.04 (0.01) 0.683 -0.001 
(0.0004)
0.023
Adjustedc 7.8 (4.2) 0.063 0.03 (0.02) 0.092 0.0001 
(0.0006)
0.497
Cord Free 25OHD
Crude
-9.6 (8.1) 0.242 -0.01 (0.03) 0.619 0.0001 
(0.001)
0.813
Adjustedd -7.3 (8.4) 0.389 -0.01 (0.03) 0.727 0.0001 
(0.001)
0.646
Cord Bio 25OHD
Crude -25.9 
(25.1)
0.303 -0.04 (0.09) 0.652 0.0001 
(0.003)
0.970
Adjustede -19.7 
(25.5)
0.440 -0.03 (0.09) 0.754 0.002 
(0.003)
0.497
HC, Head circumference; BPD, Biparietal diameter; Bio, Bioavailable 
aValues from generalized linear model with normal distribution and identity link function
bValues from generalized linear model with gamma distribution and log link function.
cAdjusted for maternal total 25OHD, maternal pre-pregnancy Body Mass Index, infant sex 
and gestational age.  
dAdjusted for maternal free 25OHD, maternal pre-pregnancy Body Mass Index, infant sex 
and gestational age.  
eAdjusted for maternal bioavailable 25OHD, maternal pre-pregnancy Body Mass Index, infant 
sex and gestational age.
samples than in maternal samples which cord level of 
total 25OHD was about 75% of maternal level at term. 
It is noteworthy to mention that, these studies used 
liquid chromatography (LC) method to assess 25OHD 
level (16, 33, 34).In contrast, we found significantly 
higher neonatal total 25OHD than maternal total 
25OHD. It is likely that this discrepancy is due to the 
use of chemiluminescent immunoassay (CLIA) LIAISON 
in measuring total 25OHD, as higher neonatal total 
25OHD than maternal total 25OHD was also reported 
in several previous studies where CLIA LIAISON method 
was used (23, 30, 35). CLIA LIAISON is a non-extracting 
method which may not fully dissociate 25OHD from 
VDBP especially in maternal samples that have high 
VDBP concentrations. Nonetheless, CLIA LIAISON 
method has a high throughput, satisfactory precision 
and accuracy, as compare to LC method. In addition, 
the discrepancy may be related to the maternal vitamin 
D status. Novakovic et al. (36) in their analysis showed 
significantly higher neonatal 25OHD than maternal 
25OHD was observed at lowest quartile of maternal 
25OHD (25OHD ≤46nmol/L)  but was not apparent at 
higher maternal 25OHD. In this study, approximately 
61% of pregnant women had 25OHD ≤50nmol/L. 
Thus, higher neonatal 25OHD than maternal 25OHD 
is expected 
An early study by Bouillon et al. (37) showed a strong 
correlation between maternal and cord free 25OHD 
(r=0.86) suggesting facilitated transfer of free 25OHD 
through the placenta. Nevertheless, our results showed 
only modest correlations (r≈0.4) between maternal 
bioavailable and free 25OHD with cord bioavailable 
and free 25OHD. This finding did not suggest transfer 
of maternal bioavailable and free 25OHD to the fetus 
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reported that both total and free 25OHD in the second 
trimester was negatively associated with birth weight in 
the crude model, but the associations attenuated after 
it was adjusted for several variables. Our finding is 
consistent with theirs in which we found no associations 
between maternal and cord free and bioavailable 
25OHD with birth weight and other parameters in crude 
and adjusted models. 
This was a preliminary study conducted in a private 
hospital setting. The sample size was small. Thus, we 
had a limited power to observe significant associations. 
Besides, the results might not generalise to larger 
Malaysian population. However, this preliminary study 
provides new insights into the associations between free 
and bioavailable 25OHD with neonatal anthropometric 
measurements. Free and bioavailable 25OHD were 
estimated based on published mathematical models that 
utilised average binding coefficient of VDBP instead of 
direct measurement. However, preliminary data from 
commercially available immunoassay showed good 
correlations between direct measured free 25OHD 
with calculated free 25OHD (40), (41). Different VDBP 
genotypes may have distinct VDBP binding affinity for 
25OHD. Monoclonal VDBP assay used in this study 
was sensitive to VDBP variant GC1f. This may result in 
lower measured VDBP level in monoclonal VDBP assay 
compared to the polyclonal VDBP assay, thus bias in 
measuring VDBP level in genetically mixed populations 
(41). However, our study population was homogenous. 
The use of monoclonal assay should not have any great 
impact on our results. Likewise, measuring VDBP levels 
by polyclonal assay may differ according to the assay 
technique and vary from batch to batch. There is a need 
for standardization of the assay measuring free 25OHD 
and VDBP. 
Despite these limitations, we comprehensively assessed 
total, free and bioavailable 25OHD in maternal and cord 
blood, attempting to understand their correlations and 
provide insight into maternal-fetal transfer of vitamin D 
metabolites. To the best of our knowledge, this is the 
first study to examine the associations of both maternal 
and cord free and bioavailable 25OHD with neonatal 
anthropometric measurements. We assessed the 
associations of maternal and cord vitamin D metabolites 
with outcomes concurrently. We then adjusted these 
associations with corresponding maternal or cord 
vitamin D metabolites to examine whether maternal or 
cord vitamin D metabolites, which are associated with 
birth outcomes. Although the observed associations 
between vitamin D metabolites and birth outcomes 
are small, these associations may reflect changes in 
fetal programming  which may have long-term health 
consequences.
CONCLUSION
Our study reported a suboptimal vitamin D status 
in pregnant women and neonates from high social 
economic status. Also, we demonstrated that maternal 
total 25OHD but not cord total 25OHD are associated 
with birth weight and head circumferences. These 
findings suggested that the effect of 25OHD on birth 
weight and head circumferences are likely to be 
mediated through the placenta. Our findings did not 
suggest causative relationships between total 25OHD 
and birth outcomes. However, the suggested associations 
could encourage further research in larger sample size. 
Notably, future research might lead to the establishment 
of the causative relationships and plausible mechanisms 
between maternal and cord 25OHD with neonatal 
anthropometric measurements at birth.  
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